Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: A Potential Relationship Between Treatment With Tyrosine Kinase Inhibitors and Erectile Dysfunction in Male Patients With Chronic Myeloid Leukemia

View source ↗

Summary

A clinical trial is recruiting to investigate whether tyrosine kinase inhibitors used to treat Chronic Myeloid Leukemia are associated with erectile dysfunction…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tyrosine kinase inhibitors (class) (tyrosine kinase inhibitor)

Snippet

Sponsor: Azienda USL Reggio Emilia - IRCCS | Conditions: Chronic Myelocytic Leukemia, Erectile Dysfunctions | Status: RECRUITING